Exane Derivatives Merck & Co., Inc. Call Options Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
Call Options
1 transactions
Others Institutions Holding MRK
# of Institutions
3,808Shares Held
1.92BCall Options Held
13.4MPut Options Held
10.6M-
Vanguard Group Inc Valley Forge, PA245MShares$24.9 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$21.1 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$12 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$7.38 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$5.81 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $258B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...